Supplementary Table 1 - Periocular Basal Cell Carcinoma Treated with Imiquimod 5%: A Systematic Review of Efficacy, Safety, and Cosmetic Outcomes
Published: 29 April 2025| Version 1 | DOI: 10.17632/ch3rms53v9.1
Contributors:
, , Description
Supplementary Table 1 for JAAD submission: Search strategy for systematic review
Files
Categories
Management, Basal Cell Carcinoma, Eyelid, Systematic Review, Drug Safety, Efficacy Assessment, Imiquimod